PCOS is four conditions, not one: the phenotype framework

PCOS as commonly defined — the Rotterdam criteria with three out of three features (irregular cycles, hyperandrogenism, polycystic ovaries on ultrasound) — captures a heterogeneous group of women with different underlying drivers. The phenotype framework popularized by integrative endocrinology recognizes four distinct patterns, each with different treatment implications.

Phenotype 1: Insulin-resistant PCOS

The most common form, accounting for roughly 70% of PCOS cases. Driven by hyperinsulinemia, which directly stimulates ovarian androgen production and reduces sex hormone-binding globulin (SHBG), raising free testosterone. Clinical features: weight gain (particularly abdominal), skin tags, acanthosis nigricans (velvety darkening at neck/armpits), fasting glucose elevation or insulin resistance markers on labs.

Treatment alignment: weight management (lifestyle, GLP-1 medications), insulin sensitizers (metformin), low-glycemic diet, resistance training. Spironolactone for androgen symptoms (acne, hirsutism). Hormonal contraception if cycle regulation needed and pregnancy not currently planned.

Phenotype 2: Inflammatory PCOS

Driven by chronic low-grade inflammation interfering with ovulation. May overlap with insulin resistance but is distinguishable when inflammation markers (hs-CRP, ferritin, white count) are elevated without significant insulin issues. Clinical features: unexplained fatigue, joint pain, headaches, skin issues (eczema, psoriasis), gut symptoms, autoimmune comorbidities.

Treatment alignment: anti-inflammatory diet (Mediterranean pattern, elimination of identified triggers), omega-3 fatty acids, vitamin D repletion if low, gut health attention, stress management. Spironolactone for symptoms. Underlying autoimmune workup if signal strong.

Phenotype 3: Adrenal PCOS

Roughly 10% of cases. Driven by adrenal androgen excess rather than ovarian androgen excess. Distinguished by elevated DHEA-sulfate (DHEA-S) on labs with relatively normal testosterone. Clinical features: stress-triggered symptom flares, anxiety, sleep disruption, weight pattern more diffuse than abdominal.

Treatment alignment: stress modulation (this is the primary intervention — not optional), sleep optimization, adrenal-supportive nutrition, sometimes low-dose adrenal cortisol replacement under endocrinology supervision. Hormonal contraception and metformin are less effective for this phenotype.

Phenotype 4: Post-pill PCOS

Often a temporary state after stopping hormonal contraception. The pill suppresses the HPO axis; some women take 6–18 months to re-establish ovulatory cycles after discontinuation. During this window, labs may meet PCOS criteria, but the underlying physiology often recovers.

Treatment alignment: time, supportive nutrition, sleep, avoiding additional stressors. If ovulation hasn't resumed by 12 months post-pill, full PCOS workup to identify which of the first three phenotypes is actually present.

Why typing matters

Metformin is highly effective for insulin-resistant PCOS, modestly helpful for inflammatory PCOS, and largely ineffective for adrenal PCOS. Hormonal contraception masks but doesn't address underlying drivers in any type. Spironolactone treats androgen symptoms across types but doesn't address the root cause in inflammatory or adrenal types. Mistyping leads to "treatment-resistant PCOS" that's actually a wrong-target problem.

How to identify your phenotype

Workup that distinguishes them: comprehensive metabolic panel + fasting insulin + 2-hour glucose tolerance test (for insulin-resistant); hs-CRP, ESR, vitamin D, ferritin (for inflammatory); DHEA-S, cortisol pattern, salivary or 24-hour urine cortisol (for adrenal); pill history and timing (for post-pill). Combined with clinical history. The PCOS Phenotype Quiz tool offers a preliminary estimate that informs the conversation with your clinician.

Informational only — PCOS workup and treatment require evaluation by a clinician.